GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

National Institutes of Health (NIH)

Status and phase: Unknown; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: GBR 12909

Study type: Interventional

Funder types: NIH

Identifiers

NCT00089687

NIDA-CPU-0005-1

Details and patient eligibility

About

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Full description

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.

Sex: All

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be within 20% of ideal body weight and must weigh at least 45 kg.
• Must understand the study procedures and provide written informed consent.
• Must meet DSM-4 criteria for abuse or dependence on cocaine.
• Must be non-treatment seeking at the time of the study.

Exclusion criteria

• Please contact the study site for more information.